Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GAURAV AGARWAL

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1033432109
CMS profile
92099
Location
MERRILLVILLE, IN

General Payments · PY2018–2024

$8,213.23

  • Reported across 203 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$761.05

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $743.79 34
Education $17.26 2

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,703.77 22
PY2019 $433.28 25
PY2020 $285.63 12
PY2021 $620.24 33
PY2022 $946.00 52
PY2023 $463.26 23
PY2024 $761.05 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $14.24 02/01/2024 Food and Beverage Undisputed 01/23/2026 1111510025 CMS
Amgen Inc. $16.42 05/02/2024 Food and Beverage Undisputed 01/23/2026 1111510027 CMS
Amgen Inc. $16.87 09/05/2024 Food and Beverage Undisputed 01/23/2026 1111510029 CMS
Amgen Inc. $14.51 10/17/2024 Food and Beverage Undisputed 01/23/2026 1111510031 CMS
Ardelyx, Inc. $31.89 02/07/2024 Food and Beverage Undisputed 01/23/2026 1146667011 CMS
Ardelyx, Inc. $26.48 03/21/2024 Food and Beverage Undisputed 01/23/2026 1146667013 CMS
Ardelyx, Inc. $15.22 08/29/2024 Food and Beverage Undisputed 01/23/2026 1146667015 CMS
Ardelyx, Inc. $17.46 09/26/2024 Food and Beverage Undisputed 01/23/2026 1146667017 CMS
Ardelyx, Inc. $24.92 11/08/2024 Food and Beverage Undisputed 01/23/2026 1146667019 CMS
AstraZeneca Pharmaceuticals LP $77.27 01/17/2024 Food and Beverage Undisputed 01/23/2026 1105779944 CMS
AstraZeneca Pharmaceuticals LP $24.19 01/18/2024 Food and Beverage Undisputed 01/23/2026 1104774164 CMS
AstraZeneca Pharmaceuticals LP $19.35 04/10/2024 Food and Beverage Undisputed 01/23/2026 1104729783 CMS
AstraZeneca Pharmaceuticals LP $31.21 07/26/2024 Food and Beverage Undisputed 01/23/2026 1105397578 CMS
AstraZeneca Pharmaceuticals LP $19.81 10/03/2024 Food and Beverage Undisputed 01/23/2026 1104692002 CMS
AstraZeneca Pharmaceuticals LP $13.24 10/24/2024 Food and Beverage Undisputed 01/23/2026 1105838621 CMS
Fresenius USA Marketing, Inc. $23.64 01/11/2024 Food and Beverage Undisputed 01/23/2026 1154204422 CMS
Fresenius USA Marketing, Inc. $4.53 01/17/2024 Food and Beverage Undisputed 01/23/2026 1154199311 CMS
Fresenius USA Marketing, Inc. $14.52 01/17/2024 Food and Beverage Undisputed 01/23/2026 1154199313 CMS
Fresenius USA Marketing, Inc. $24.35 01/25/2024 Food and Beverage Undisputed 01/23/2026 1154204424 CMS
Fresenius USA Marketing, Inc. $16.89 02/22/2024 Food and Beverage Undisputed 01/23/2026 1154199315 CMS
Fresenius USA Marketing, Inc. $23.51 04/04/2024 Food and Beverage Undisputed 01/23/2026 1154204420 CMS
Fresenius USA Marketing, Inc. $1.64 05/29/2024 Food and Beverage Undisputed 01/23/2026 1154199309 CMS
Fresenius USA Marketing, Inc. $23.18 05/29/2024 Food and Beverage Undisputed 01/23/2026 1154204418 CMS
GlaxoSmithKline, LLC. $13.70 05/09/2024 Food and Beverage Undisputed 01/23/2026 1116218343 CMS
Novo Nordisk Inc $24.69 06/06/2024 Food and Beverage Undisputed 01/23/2026 1096579739 CMS
Novo Nordisk Inc $19.56 08/01/2024 Food and Beverage Undisputed 01/23/2026 1097115643 CMS
OPKO Pharmaceuticals, LLC $23.95 02/08/2024 Food and Beverage Undisputed 01/23/2026 1112841614 CMS
OPKO Pharmaceuticals, LLC $21.01 06/27/2024 Food and Beverage Undisputed 01/23/2026 1112841616 CMS
OPKO Pharmaceuticals, LLC $24.01 08/28/2024 Food and Beverage Undisputed 01/23/2026 1112841618 CMS
Otsuka America Pharmaceutical, Inc. $20.55 08/01/2024 Food and Beverage Undisputed 01/23/2026 1118848684 CMS
Otsuka America Pharmaceutical, Inc. $18.19 09/25/2024 Food and Beverage Undisputed 01/23/2026 1118848686 CMS
Otsuka America Pharmaceutical, Inc. $26.49 10/10/2024 Food and Beverage Undisputed 01/23/2026 1118848688 CMS
SCPHARMACEUTICALS INC. $30.57 08/08/2024 Food and Beverage Undisputed 01/23/2026 1132292200 CMS
Travere Therapeutics, Inc. $25.73 08/21/2024 Food and Beverage Undisputed 01/23/2026 1149914608 CMS
Travere Therapeutics, Inc. $0.37 08/22/2024 Education Undisputed 01/23/2026 1149914600 CMS
Travere Therapeutics, Inc. $16.89 08/22/2024 Education Undisputed 01/23/2026 1149914604 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.